Inhibitory of idoxifene on hepatic fibrosis in rats

Acta Pharmacologica Sinica

Volumn 26, Issue 5, 2005, Pages 581-586

  Zhou, Ya Jun ^a   Yin, Dong Mei ^a   Chen, Hong Shan ^a   Shi, Jian Hua ^a   Sha, Bao Xi ^a   Wang, Xing ^a  

^a NANTONG MEDICAL COLLEGE   (China)

Author keywords

Fibrosis; Hepatic stellate cell; Idoxifene; Liver; Oxidative stress

Indexed keywords

BROXURIDINE; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; DIMETHYLNITROSAMINE; GLUTATHIONE PEROXIDASE; IDOXIFENE; NITRILOTRIACETATE IRON; SELECTIVE ESTROGEN RECEPTOR MODULATOR; ANTIOXIDANT; COLLAGEN TYPE 1; DRUG DERIVATIVE; PYRROLIDINO-4-IODOTAMOXIFEN; SUPEROXIDE DISMUTASE; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LIVER CELL CULTURE; LIVER FIBROSIS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STELLATE CELL; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; EXPERIMENTAL LIVER CIRRHOSIS; LIVER; LIVER CELL; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; DIMETHYLNITROSAMINE; GLUTATHIONE PEROXIDASE; HEPATOCYTES; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; TAMOXIFEN;

EID: 18744395529     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00082.x     Document Type: Article

References (27)

1. Yasuda M, Shimizu I, Shiba M, Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999; 29: 719-27.
2. Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, et al. Effects of Sho-saiko-to, a Japanese herbal madicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149-60.
3. Johnston SR, Boeddinghaus IM, Riddler S, Haynes BP, Hardcastle IR, Rowlands M, et al. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis. Cancer Res 1999; 59: 3646-51.
4. Hirsimaki P, Aaltonen A, Mantyla E. Toxicity of antiestrogens. Breast J 2002; 8: 92-6.
5. Baumer AT, Wassmann S, Ahlbory K, Strehlow K, Muller C, Sauer H, et al. Reduction of oxidative stress and ATI receptor expression by the selective oestrogen receptor modulator idoxifene. Br J Pharmacol 2001; 134: 579-84.
6. Omoya T, Shimizu I, Zhou Y, Okamura Y, Inoue H, Lu G, et al. Effects of idoxifene and estradiol on NF-kappaB activation in cultured rat hepatocytes undergoing oxidative stress. Liver 2001; 21: 183-91.
7. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 2000; 21: 49-98.
8. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-50.
9. Alcolado R, Arthur MJ, Iredale JP. Pathogenesis of liver fibrosis. Clin Sci (Lond) 1997; 92: 103-12.
10. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-49.
11. Shimizu I, Ichihara A, Nakamura T. Hepatocyte growth factor in ascites from patiens with cirrhosis. J Biochem 1991; 109: 14-8.
12. Morel I, Lescoat G, Cillard J, Pasdeloup N, Brissot P, Cillard P. Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Biochem Pharmacol 1990; 39: 1647-55.
13. Liu Y, Shimizu I, Omoya T, Ito S, Gu XS, Zuo J. Protective effects of estradiol on hepatocytic oxidative damage. World J Gastroenterol 2002; 8: 363-6.
14. Zhou YJ, Yin DM, Chen HS, Zhu HX, Wan X. Effects of blocking transforming growth factor signaling on culture-activated rat hepatic stellate cells. Chin J Hepatol 2003; 11: 282-4.
15. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF α and collagen type I mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96: 2461-6.
16. Fernandez-Checa JC, Kaplowitz N, Garcia-Ruiz C, Colell A. Mitochondrial glutathione: importance and transport. Semin Liver Dis 1998; 18: 389-401.
17. Maher JJ. Leukocytes as modulators of stellate cell activation. Alcohol Clin Exp Res 1999; 23: 917-21.
18. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998; 27: 720-6.
19. Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. Gastroenterology 2001; 121: 685-98.
20. Czaja MJ. Induction and regulation of hepatocyte apoptosis by oxidative stress. Antioxid Redox Signal 2002; 4: 759-67.
21. Canbay A, Guicciardi ME, Higuchi H, Feldstein A, Bronk SF, Rydzewski R, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003; 112: 152-9.
22. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, et al. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323-30.
23. Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem 2001; 276: 49077-82.
24. Zhou YJ, Chen HS, Sha BX. Antiapoptotic mechanisms of idoxifene on cultured rat hepatocytes undergoing oxidative stress. Chin Pharm J 2005; 40: 278-81.
25. 4-induced liver fibrosis in rats. World J Gastroenterol 2002; 8: 883-7.
26. Burger HG. Selective oestrogen receptor modulators. Horm Res 2000; 53 Suppl 3: 25-9.
27. Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004; 25: 45-71.